• BCRA has assigned BBB- credit rating to Tchaikapharma

    July 8, 2022

    On July 7, 2022, the Bulgarian Credit Rating Agency (BCRA) has awarded the company with the highest market capitalization on the Bulgarian Stock Exchange Tchaikapharma a long-term credit rating of “BBB-” and a short-term “A” on a national scale. With this, BCRA expresses its opinion that the company maintains a very good financial position with low levels of indebtedness, high creditworthiness, formed satisfactory liquidity, allowing it to timely service its obligations. According to the BCRA’s rating scale, the rating assigned corresponds to an ‘investment grade’ credit rating.

    According to the agency’s analysis, the company is a well-established player in the local market with a long-standing (22 years) presence, a well-known name and reputation and an extensive commercial network.